Ursodeoxycholic acid for treatment of no
β
Keith D. Lindor; Kris V. Kowdley; E. Jenny Heathcote; M. Edwyn Harrison; Roberta
π
Article
π
2004
π
John Wiley and Sons
π
English
β 124 KB
π 2 views
No effective medical therapy is available for all patients with nonalcoholic steatohepatitis (NASH). Ursodeoxycholic acid (UDCA) has been suggested to be of benefit based on open label clinical studies. We randomized 166 patients with liver biopsy-proven NASH to receive between 13 and 15 mg/kg/d of